Site icon Vision Science Academy

Advances in Screening for Amblyopia

Salal Khan, M.Optom

Student, Galgotias University, U.P, India

 

Introduction

Amblyopia is the most common cause of monocular visual impairment in children, with a prevalence of 2–3%. Not only is one eye’s visual acuity reduced, but also binocular vision, fellow eye deficiencies, eye-hand coordination, reading, and self-perception may all be affected.(1-3)

There are emerging technologies that show promise for accessible, early, and accurate amblyopia detection rather than risk factors during preschool vision screening, such as:

  1. Retinal birefringence,
  2. Optokinetic nystagmus visual acuity screening, and
  3. Artificial intelligence

Binocular Retinal Birefringence (RBF) Screening

RBF scanning is a new technique that has been created to identify strabismus and amblyopia. RBF scanning makes use of the radially organised Henle fibres and distinctive architecture of the human fovea.(4-5)

Optokinetic Nystagmus VA Screening

 Artificial Intelligence and Screening

Conclusion

The development of new screening techniques that specifically target amblyopia rather than risk factors shows potential for more precise preschool screening. Together with recent developments in amblyopia screening, we anticipate better visual results for kids who have amblyopia.

Conflict of interest: Nil

 

References:

  1. Friedman DS, Repka MX, Katz J, et al. Prevalence of amblyopia and strabismus in White and African American children aged 6 through 71 months the Baltimore Pediatric Eye Disease Study. Ophthalmology. 2009;116(2128–34):e1-2.
  2. Giordano L, Friedman DS, Repka MX, et al. Prevalence of refractive error among preschool children in an urban population: the Baltimore Pediatric Eye Disease Study. Ophthalmology. 2009;116:739-46 e1–4.
  3. Multi-Ethnic Pediatric Eye Disease Study. Prevalence of amblyopia and strabismus in African American and Hispanic children ages 6 to 72 months the Multi-Ethnic Pediatric Eye Disease Study. Ophthalmology. 2008;115:1229-36 e1.
  4. Jost RM, Yanni SE, Beauchamp CL, et al. Beyond screening for risk factors: objective detection of strabismus and amblyopia. JAMA Ophthalmol. 2014;132:814–20.
  5. Jost RM, Stager D Jr, Dao L, Katz S, McDonald R, Birch EE. High specificity of the pediatric vision scanner in a private pediatric primary care setting. J AAPOS. 2015;19:521–5.
  6. Turuwhenua J, Yu TY, Mazharullah Z, Thompson B. A method for detecting optokinetic nystagmus based on the optic flow of the limbus. Vis Res. 2014;103:75–82.
  7. Sangi M, Thompson B, Turuwhenua J. An optokinetic nystagmus detection method for use with young children. IEEE J Transl Eng Health Med. 2015;3:1600110.
  8. Wang J, Neely DE et al. A pilot randomized clinical trial of intermittent occlusion therapy liquid crystal glasses versus traditional patching for treatment of moderate unilateral amblyopia. J AAPOS. 2016;20:326–31.
  9. Wang J, Jin J, Malik A, et al. Feasibility of monitoring compliance with intermittent occlusion therapy glasses for amblyopia treatment. J AAPOS. 2019;23:205:e1–205.e5.
  10. Handa T, Ishikawa H, Shoji N, et al. Modified iPad for treatment of amblyopia: a preliminary study. J AAPOS. 2015;19:552–4.
  11. Wata Y, Handa T, Ishikawa H, Goseki T, Shoji N. Comparison between amblyopia treatment with glasses only and combination of glasses and opentype binocular ‘‘Occlu-Pad’’ device. Biomed Res Int. 2018;2018:2459696. 52. Pediatric Eye Disease Investigator Group. Randomized trial to evaluate combined patching and atropine for residual amblyopia. Arch Ophthalmol. 2011;129:960–2.
  12. Birch EE, Morale SE, Jost RM, et al. Assessing suppression in amblyopic children with a dichoptic eye chart. Invest Ophalmol Vis Sci. 2016;57:5649–54.
  13. Hess RF, Thompson B. Amblyopia, and the binocular approach to its therapy. Vis Res. 2015;114:4–16.
Exit mobile version